Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above

Launched by CHENGDU COENBIOTECH CO., LTD ·

Keywords

ClinConnect Summary

This clinical trial is studying a new skin test called EEC to see how well it works and how safe it is for diagnosing tuberculosis (TB) infection in people aged 3 years and older. Tuberculosis is a lung infection caused by bacteria, and it can be hard to diagnose accurately. This study compares EEC to existing tests to check if it can detect TB infection reliably in different age groups, including children, adults, and older adults. The trial also looks at how the test performs after people receive the BCG vaccine, which is given to protect against TB.

People who are 3 years or older and meet certain health criteria may be eligible to join. Participants will undergo skin tests with EEC and other standard tests, and some may be vaccinated with BCG to see how the tests respond afterward. Throughout the study, the safety of EEC will be closely monitored. If you join, you can expect to have skin tests done and follow-up visits to assess the results and any side effects. This study is currently recruiting participants and aims to improve TB diagnosis with a simpler and reliable test for a wide range of people.

Gender

ALL

Eligibility criteria